Hormonal therapy stays the cure of 1st option for metastatic people with endocrine-responsive breast cancer (LoE 1a A, In the past ++). The sequential use with the obtainable drugs is determined by the individual pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at the time of analysis https://judyt753rbl2.bleepblogs.com/profile